Lipids/CKD Flashcards
CKD is defined as ____ or more months of either kidney damage or eGFR < _____.
3, 60
Dominant risk factors for CKD
DM and HTN
Four interventions to reduce CKD progression
blood pressure control goal <130/80
use of ACE/ARB (not together) for albuminuria
DM control HgBA1C target <7%
correction of metabolic acidosis
eGFR Stages of CKD
Stage 1- 90-100 normal Stage 2- 60-89% mild Stage 3- 30-59% moderate Stage 4- 15-29% severe Stage 5- 14% and less- failure
Which stage of CKD? eGFR 90-100%, asymptomatic, with health issues such as DM, HTN, and obesity
Stage 1
Modifiable risk factors for CKD
DM
HTN
frequent NSAID use
hx of AKI
Non-modifiable risk factors for CKD
family hx of CKD
age 60 or older
ethnicity- AA, Hispanic, Asian/PI, or American Indian
What lab tests are used to diagnose CKD?
eGFR
ACR- albumin to creatinine ratio, urine (kidney damage marker)
Normal UACR level
<30
Severe albuminuria UACR level
> 300
Urine dipstick proteinuria if level is > ____.
30
Especially avoid these medications in CKD
NSAIDs Bisphosphonates IV contrast Metformin RAAS blockers
Starting at stage 3 CKD these additional labs are needed
Serum albumin
phosphorus
calcium
intact parathyroid hormone (PTH)
At what stage should nephrology be consulted in patients with CKD
Stage 3 or eGFR <30
or persistent albuminuria UACR >300
Clinicians should not only check patients blood creatinine levels but also check their ______.
Urine- low pH, high specific gravity, protein, RBC/WBCs are early indicators of potential issues.
In order for erythropoiesis-stimulating agents (ESA) to be effective, this medication is needed
Iron supplementation
Sodium should be limited to ___g/day and phosphorus ___-____mg/day in patients with CKD
2
800-1000
Animal protein consumption should be reduced to
___-___g/kg/day in CKD patients
0.6-0.8
What stage of CKD do complications usually begin>
Stage 3 (anemia, bone/mineral issues, CV dz, low serum albumin)
Common meds that require dose reduction
Allopurinol Gabapentin Reglan Narcotics- methadone/fentanyl Beta-blockers Digoxin Statins- lova, prava, simva, fluva, rosuva Antimicrobials- sulfa, Macrobid, aminoglycosides Lovenox methotrexate colchicine
Treatment of hyperkalemia in CKD
Stop NSAIDs and Cox-2 inhibitors
Stop K+ sparing diuretics (spironolactone)
Avoid salt substitutes
CKD increases the risk for ____ disease.
CV
Increased waist circumference, increased trigs, decreased HDL, increased BP, and increased fasting glucose are indicators of:
metabolic syndrome
How do ACE/ARBs help with CKD?
lowers BP and reduces hyperfiltration injury inpatients with limited nephrons
What is the primary intervention for metabolic syndrome?
lifestyle therapy
Statin intensity for clinical ASCVD
high intensity if <75y
mod-high if >75y
Statin intensity for age 40-75 with DM and LDL 70-189
moderate intensity, consider increase if multiple ASCVD risk factors
Severe primary hypercholesterolemia LDL >190 initiate ____ intensity statin without calculating ASCVD risk
high